Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "J01DD" (28)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Ceftazidime (J01DD02) 3 products
WHO-DDD
DrugBank.ca
IP
Fortam 1 g
Durchstechflasche(n)
9.69
26.95
10 %
Powder for injection- or infusion solution: Ceftazidimum 1 g
Sandoz
Pharmaceuticals AG
A / SL
FB
G
IP
Fortam 2 g
Durchstechflasche(n)
16.73
34.60
10 %
Powder for injection- or infusion solution: Ceftazidimum 2 g
Sandoz
Pharmaceuticals AG
A / SL
FB
G
IP
Fortam 500 mg
Durchstechflasche(n)
5.29
15.00
10 %
Dry substance: Ceftazidimum 500 mg
Sandoz
Pharmaceuticals AG
A / SL
FB
G
Ceftriaxone (J01DD04) 20 products
WHO-DDD
DrugBank.ca
L
IP
Rocephin 1 g i.v.
1 +
11.22
21.10
10 %
Lyophilisate and solvent: Ceftriaxonum 1 g
Roche Pharma
(Schweiz) AG
A / SL / SO
FB
G
L
IP
Rocephin 2 g i.v.
Durchstechflasche(n)
23.41
41.05
10 %
Lyophilisate: Ceftriaxonum 2 g
Roche Pharma
(Schweiz) AG
A / SL / SO
FB
G
L
IP
Ceftriaxon Labatec 2 g
i.v.
2 g
9.90
27.20
10 %
Dry substance: Ceftriaxonum 2000 mg
Labatec Pharma SA
A / SL / SG
FB
G
L
IP
Ceftriaxon Labatec 2 g
i.v.
10 x 2 g
84.15
107.95
10 %
Dry substance: Ceftriaxonum 2000 mg
Labatec Pharma SA
A / SL / SG
FB
G
L
IP
Ceftriaxon Labatec 1 g
i.v./i.m.
1 g
6.15
15.90
10 %
poudre pour solution injectable: Ceftriaxonum 1000 mg
Labatec Pharma SA
A / SL / SG
FB
G
L
IP
Ceftriaxon Labatec 1 g
i.v./i.m.
10 x 1 g
52.25
73.25
10 %
poudre pour solution injectable: Ceftriaxonum 1000 mg
Labatec Pharma SA
A / SL / SG
FB
G
L
IP
Rocephin 1 g i.m.
1 +
11.22
28.60
10 %
Lyophilisate and solvent: Lidocaini Hydrochloridum Anhydricum 35mg / 3.5ml
Lyophilisate and solvent: Ceftriaxonum 1 g
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
Rocephin 500 mg i.v.
1 +
11.15
28.55
10 %
Lyophilisate and solvent: Ceftriaxonum 500 mg
Roche Pharma
(Schweiz) AG
A / SL
FB
G
IP
Ceftriaxon Lagap 500 mg
i.v.
PR
PR
k.A.
Polvere per soluzione iniettabile: Ceftriaxonum 500 mg
Lagap SA
A
FB
G
IP
Ceftriaxon Lagap 500 mg
i.v.
10
PR
PR
k.A.
Polvere per soluzione iniettabile: Ceftriaxonum 500 mg
Lagap SA
A
FB
G
IP
Ceftriaxon Lagap 1000 mg
i.v./i.m.
PR
PR
k.A.
Polvere per soluzione iniettabile: Ceftriaxonum 1000 mg
Lagap SA
A
FB
G
IP
Ceftriaxon Lagap 1000 mg
i.v./i.m.
10
PR
PR
k.A.
Polvere per soluzione iniettabile: Ceftriaxonum 1000 mg
Lagap SA
A
FB
G
IP
Ceftriaxon Lagap 2000 mg
i.v.
PR
PR
k.A.
Polvere per soluzione per infusione: Ceftriaxonum 2000 mg
Lagap SA
A
FB
G
IP
Ceftriaxon Lagap 2000 mg
i.v.
10
PR
PR
k.A.
Polvere per soluzione per infusione: Ceftriaxonum 2000 mg
Lagap SA
A
FB
G
IP
Ceftriaxon Labatec 250 mg
i.m.
10 x 250 mg
PR
PR
k.A.
poudre pour solution injectable: Ceftriaxonum 250 mg
Labatec Pharma SA
A
FB
G
IP
Ceftriaxon Labatec 500 mg
i.v.
10 x 500 mg
PR
PR
k.A.
poudre pour solution injectable: Ceftriaxonum 500 mg
Labatec Pharma SA
A
FB
G
IP
Ceftriaxon OrPha 1 g
1 g
11.50
25.50
k.A.
OrPha Swiss GmbH
A
FB
G
IP
Ceftriaxon OrPha 2 g
2 g
17.00
35.90
k.A.
OrPha Swiss GmbH
A
FB
G
IP
Ceftriaxon OrPha 1 g
5 x 1 g
PR
PR
k.A.
OrPha Swiss GmbH
A
FB
G
IP
Ceftriaxon OrPha 2 g
5 x 2 g
PR
PR
k.A.
OrPha Swiss GmbH
A
FB
G
Cefpodoxime (J01DD13) 4 products
WHO-DDD
DrugBank.ca
IP
CI
Cefpodoxim Sandoz 100
10 Tablet(s)
5.10
14.80
10 %
Coated tablets: Cefpodoximum 100 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Cefpodoxim Sandoz 100
20 Tablet(s)
8.99
26.20
10 %
Coated tablets: Cefpodoximum 100 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Cefpodoxim Sandoz 200
10 Tablet(s)
10.22
27.55
10 %
Coated tablets: Cefpodoximum 200 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Cefpodoxim Sandoz 200
20 Tablet(s)
18.35
36.35
10 %
Coated tablets: Cefpodoximum 200 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
Ceftazidime and Beta-Lactamase Inhibitor (J01DD52) 1 products
WHO-DDD
DrugBank.ca
L
IP
Zavicefta
10
1151.31
1268.55
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: 2 Active Agents
Pfizer AG
A / SL
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
